175 related articles for article (PubMed ID: 17028131)
61. Inhibition of Cu-amyloid-β by using bifunctional peptides with β-sheet breaker and chelator moieties.
Jensen M; Canning A; Chiha S; Bouquerel P; Pedersen JT; Østergaard J; Cuvillier O; Sasaki I; Hureau C; Faller P
Chemistry; 2012 Apr; 18(16):4836-9. PubMed ID: 22422637
[TBL] [Abstract][Full Text] [Related]
62. Zn2+'s ability to alter the distribution of Cu2+ among the available binding sites of Aβ(1-16)-polyethylenglycol-ylated peptide: implications in Alzheimer's disease.
Damante CA; Ösz K; Nagy Z; Grasso G; Pappalardo G; Rizzarelli E; Sóvágó I
Inorg Chem; 2011 Jun; 50(12):5342-50. PubMed ID: 21612223
[TBL] [Abstract][Full Text] [Related]
63. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
64. Site-specific structure of Aβ(25-35) peptide: isotope-assisted vibrational circular dichroism study.
Shanmugam G; Polavarapu PL
Biochim Biophys Acta; 2013 Jan; 1834(1):308-16. PubMed ID: 22910376
[TBL] [Abstract][Full Text] [Related]
65. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
66. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
[TBL] [Abstract][Full Text] [Related]
67. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
Hou L; Zagorski MG
J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
[TBL] [Abstract][Full Text] [Related]
68. How the amyloid-β peptide and membranes affect each other: an extensive simulation study.
Poojari C; Kukol A; Strodel B
Biochim Biophys Acta; 2013 Feb; 1828(2):327-39. PubMed ID: 22975281
[TBL] [Abstract][Full Text] [Related]
69. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
Abelein A; Gräslund A; Danielsson J
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
[TBL] [Abstract][Full Text] [Related]
70. Dual role of Cu²⁺ ions on the aggregation and degradation of soluble Aβ oligomers and protofibrils investigated by fluorescence spectroscopy and AFM.
García S; Cuscó C; Brissos RF; Torrents E; Caubet A; Gamez P
J Inorg Biochem; 2012 Nov; 116():26-36. PubMed ID: 23010326
[TBL] [Abstract][Full Text] [Related]
71. Peptide-surfactant interactions: consequences for the amyloid-beta structure.
Rocha S; Loureiro JA; Brezesinski G; Pereira Mdo C
Biochem Biophys Res Commun; 2012 Mar; 420(1):136-40. PubMed ID: 22405768
[TBL] [Abstract][Full Text] [Related]
72. Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules.
Wärmländer S; Tiiman A; Abelein A; Luo J; Jarvet J; Söderberg KL; Danielsson J; Gräslund A
Chembiochem; 2013 Sep; 14(14):1692-704. PubMed ID: 23983094
[TBL] [Abstract][Full Text] [Related]
73. Effect of ferric citrate on amyloid-beta peptides behavior.
Galante D; Cavallo E; Perico A; D'Arrigo C
Biopolymers; 2018 Jun; 109(6):e23224. PubMed ID: 29897618
[TBL] [Abstract][Full Text] [Related]
74. Introduction of a fluorescent probe to amyloid-β to reveal kinetic insights into its interactions with copper(II).
Branch T; Girvan P; Barahona M; Ying L
Angew Chem Int Ed Engl; 2015 Jan; 54(4):1227-30. PubMed ID: 25529008
[TBL] [Abstract][Full Text] [Related]
75. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
76. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
[TBL] [Abstract][Full Text] [Related]
77. [Zinc-induced interactions of the metal-binding domain of beta-amyloid with nucleic acids and glycosaminoglycans].
Khmeleva SA; Kozin SA; Kiseleva YY; Mitkevich VA; Makarov AA; Radko SP
Mol Biol (Mosk); 2016; 50(6):1049-1052. PubMed ID: 28064322
[TBL] [Abstract][Full Text] [Related]
78. Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.
Altman R; Ly S; Hilt S; Petrlova J; Maezawa I; Kálai T; Hideg K; Jin LW; Laurence TA; Voss JC
Biochim Biophys Acta; 2015 Dec; 1854(12):1860-1870. PubMed ID: 26374940
[TBL] [Abstract][Full Text] [Related]
79. Probing of various physiologically relevant metals-amyloid-β peptide interactions with a lipid membrane-immobilized protein nanopore [corrected].
Asandei A; Iftemi S; Mereuta L; Schiopu I; Luchian T
J Membr Biol; 2014 Jun; 247(6):523-30. PubMed ID: 24715156
[TBL] [Abstract][Full Text] [Related]
80. An interaction of beta-amyloid with aluminium in vitro.
Exley C; Price NC; Kelly SM; Birchall JD
FEBS Lett; 1993 Jun; 324(3):293-5. PubMed ID: 8405368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
